Therapeutic Category
Secondary Hyperparathyroidism
API Technology
Synthetic
Dose From
Oral Solids
Dr Reddy's Development Status
Available
Available Regulatory Filing
USA
Canada
Europe
Australia
China
Innovator Brand (USA)
Sensipar
We are here to help, if you have any country specific requirements - please Contact Us.